# EDGAR Filing Document

**Accession Number:** 0001940173
**File Stem:** 0001104659-25-085692
**Filing Date:** 2025-8
**Character Count:** 9287
**Document Hash:** 3cda96953dca98e7cf3cb3568b272226
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-085692.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001104659-25-085692

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GV Management Company, L.L.C.
- **CENTRAL INDEX KEY:** 0001940173

**ORGANIZATION NAME:**
- **EIN:** 271343798
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-22704
- **FILM NUMBER:** 251281125

**BUSINESS ADDRESS:**
- **STREET 1:** 1600 AMPHITHEATRE PARKWAY
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043
- **BUSINESS PHONE:** 650-253-0000

**MAIL ADDRESS:**
- **STREET 1:** 1600 AMPHITHEATRE PARKWAY
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001940173

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** GV Management Company, L.L.C.

**Address:** 1600 Amphitheatre Parkway, Mountain View, CA 94043

**Telephone number:** 650-253-0000

**Name of agent for service:** Corporation Service Company

**Agent Address:** 251 Little Falls Drive, Wilmington, DE 19808

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-22704

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER              | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                    | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Alector, Inc.               | 014442107 | 06/11/2025     | Advisory vote on executive compensation                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         175866 |                0 | FOR         |                                   175866 | FOR                         |  |
| Beam Therapeutics Inc.      | 07373V105 | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |                                        0 | FOR                         |  |
| Desktop Metal, Inc.         | 25058X303 | 10/02/2024     | To approve, on a non-binding advisory basis, the executive officer compensation that will or may be paid to Desktop Metal's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement | SECTION 14A SAY-ON-PAY VOTES |        1104871 |                0 | FOR         |                                  1104871 | FOR                         |  |
| Dianthus Therapeutics, Inc. | 252828108 | 05/22/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         208697 |                0 | FOR         |                                   208697 | FOR                         |  |
| Gitlab Inc.                 | 37637K108 | 06/20/2025     | Approve, on a non-binding advisory basis, the compensation paid by GitLab Inc. to its named executive officers                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        2724712 |                0 | FOR         |                                  2724712 | FOR                         |  |
| Lyell Immunopharma, Inc.    | 55083R104 | 05/15/2025     | Approval, on a non-binding advisory basis, of the compensation of the company's named executive officers                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        5865125 |                0 | FOR         |                                  5865125 | FOR                         |  |
| Oscar Health, Inc.          | 687793109 | 06/04/2025     | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |                                        0 | FOR                         |  |
| Relay Therapeutics, Inc.    | 75943R102 | 06/06/2025     | To consider and act upon an advisory vote on the compensation of our named executive officers                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1564173 |                0 | FOR         |                                  1564173 | FOR                         |  |
| Revolution Medicines, Inc.  | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay") | SECTION 14A SAY-ON-PAY VOTES |        4080700 |                0 | FOR         |                                  4080700 | FOR                         |  |
| Spero Therapeutics, Inc.    | 84833T103 | 06/12/2025     | To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         889979 |                0 | FOR         |                                   889979 | FOR                         |  |
| Vera Therapeutics, Inc.     | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         241264 |                0 | FOR         |                                   241264 | FOR                         |  |
| Vera Therapeutics, Inc.     | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         241264 |                0 | 1 YEAR      |                                   241264 | FOR                         |  |
| Verve Therapeutics, Inc.    | 92539P101 | 06/05/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |       12168489 |                0 | FOR         |                                 12168489 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** GV Management Company, L.L.C.

**By (Signature):** Inga Goldbard

**By (Printed Signature):** Inga Goldbard

**By (Title):** General Counsel

**Date:** 08/29/2025